Validation of ZMYND8 as a new treatment target in hepatocellular carcinoma.

Sangjoon ChoiKeun-Woo LeeHyun Hee KohSujin ParkSo-Young YeoJae-Won JohMoon Seok ChoiSeok-Hyung KimCheol-Keun ParkSang-Yun Ha

Published in: Journal of cancer research and clinical oncology (2021)

ZMYND8 mRNA overexpression could be a prognostic marker of shorter RFS in HCC patients after curative resection. ZMYND8 might play an important role in the proliferation and progression of HCC and could be a promising candidate for targeted therapy.

Keyphrases

end stage renal disease
prognostic factors
chronic kidney disease
ejection fraction
newly diagnosed
peritoneal dialysis
cell proliferation
transcription factor
patient reported outcomes
rectal cancer
patient reported